Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936128 · ClinicalTrials.gov registry record · Phase 4
TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02936128: Clinical Trial Phase 4 study, sponsored by Osiris Therapeutics.
NCT02936128 is a Phase 4 study that was terminated before completion, run by Osiris Therapeutics. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02936128, a Phase 4 study, was terminated before completion, sponsored by Osiris Therapeutics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic venous leg ulcers.
Interventions
- OTHER Wound Cover
- OTHER TruSkin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Why NCT02936128 stopped before completion
NCT02936128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Wound Cover is the first listed.
NCT02936128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02936128 about?
NCT02936128 is a clinical study titled "TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers". The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic venous leg ulcers.
What is the current status of trial NCT02936128?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02936128?
The interventions under investigation include: Wound Cover (OTHER), TruSkin (OTHER).
Who is sponsoring clinical trial NCT02936128?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02936128's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia